JNCI Journal of the National Cancer Institute

MEMO TO THE MEDIA

Linda Wang and Katherine Arnold

Press Release: Longer Commute for Cancer Treatment Associated with Better Survival
J. Natl. Cancer Inst. 2003 95: 1349; doi:10.1093/jnci/95.18.1349 [Extract] [Full Text]  

Linda Wang and Katherine Arnold

Press Release: North American Mammographers Prone to More False Positives, Study Finds
J. Natl. Cancer Inst. 2003 95: 1349; doi:10.1093/jnci/95.18.1349-a [Extract] [Full Text]  

EDITORIALS

Stephen L. George

Selection Bias, Phase II Trials, and the FDA Accelerated Approval Process
J. Natl. Cancer Inst. 2003 95: 1351; doi:10.1093/jnci/djg070 [Extract] [Full Text] [PDF]  

Howard M. Sandler and Michelle L. DeSilvio

Surrogate End Points for Prostate Cancer: What Is Prostate-Specific Antigen Telling Us?
J. Natl. Cancer Inst. 2003 95: 1352; doi:10.1093/jnci/djg071 [Extract] [Full Text] [PDF]  

NEWS

Linda Wang

Central Clinical Trials Effort Draws Praise, Criticism
J. Natl. Cancer Inst. 2003 95: 1354; doi:10.1093/jnci/95.18.1354 [Extract] [Full Text]  

Tom Reynolds

Study Seeks to Clarify Genetic Basis of Prostate Cancer in African Americans
J. Natl. Cancer Inst. 2003 95: 1356; doi:10.1093/jnci/95.18.1356 [Extract] [Full Text]  

Stat Bite: Prostate Cancer Incidence and Mortality Among White and Black Men, 1975–2000
J. Natl. Cancer Inst. 2003 95: 1357; doi:10.1093/jnci/95.18.1357 [Extract] [Full Text]  

James Schultz

Data From DNA Repair Studies Questioned As Leading Researcher Investigated
J. Natl. Cancer Inst. 2003 95: 1358; doi:10.1093/jnci/95.18.1358 [Extract] [Full Text]  

Linda Wang

In Brief
J. Natl. Cancer Inst. 2003 95: 1359; doi:10.1093/jnci/95.18.1359 [Extract] [Full Text]  

Christine Theisen

For Patients, Prediction of Cancer Risk Can Be Worrisome
J. Natl. Cancer Inst. 2003 95: 1360; doi:10.1093/jnci/95.18.1360 [Extract] [Full Text]  

Resources for Cancer Risk Assessment
J. Natl. Cancer Inst. 2003 95: 1361; doi:10.1093/jnci/95.18.1361 [Extract] [Full Text]  

Clinical Trials Resources
J. Natl. Cancer Inst. 2003 95: 1354; doi:10.1093/jnci/95.18.1354-a [Extract] [Full Text]  

Awards, Appointments, Announcements
J. Natl. Cancer Inst. 2003 95: 1361; doi:10.1093/jnci/95.18.1361-a [Extract] [Full Text]  

COMMENTARY

Kevin Dobbin, Joanna H. Shih, and Richard Simon

Questions and Answers on Design of Dual-Label Microarrays for Identifying Differentially Expressed Genes
J. Natl. Cancer Inst. 2003 95: 1362; doi:10.1093/jnci/djg049 [Extract] [Full Text] [PDF] [Supplemental Information]  

ARTICLES

Elizabeth B. Lamont, Davinder Hayreh, Kate E. Pickett, James J. Dignam, Marcy A. List, Kerstin M. Stenson, Daniel J. Haraf, Bruce E. Brockstein, Sarah A. Sellergren, and Everett E. Vokes

Is Patient Travel Distance Associated With Survival on Phase II Clinical Trials in Oncology?
J. Natl. Cancer Inst. 2003 95: 1370; doi:10.1093/jnci/djg035 [Abstract] [Full Text] [PDF]  

Anthony V. D’Amico, Judd W. Moul, Peter R. Carroll, Leon Sun, Deborah Lubeck, and Ming-Hui Chen

Surrogate End Point for Prostate Cancer–Specific Mortality After Radical Prostatectomy or Radiation Therapy
J. Natl. Cancer Inst. 2003 95: 1376; doi:10.1093/jnci/djg043 [Abstract] [Full Text] [PDF]  

Joann G. Elmore, Connie Y. Nakano, Thomas D. Koepsell, Laurel M. Desnick, Carl J. D’Orsi, and David F. Ransohoff

International Variation in Screening Mammography Interpretations in Community-Based Programs
J. Natl. Cancer Inst. 2003 95: 1384; doi:10.1093/jnci/djg048 [Abstract] [Full Text] [PDF] [Supplemental Information]  

Catherine A. Burkhart, Andy J. Cheng, Janice Madafiglio, Maria Kavallaris, Mario Mili, Glenn M. Marshall, William A. Weiss, Levon M. Khachigian, Murray D. Norris, and Michelle Haber

Effects of MYCN Antisense Oligonucleotide Administration on Tumorigenesis in a Murine Model of Neuroblastoma
J. Natl. Cancer Inst. 2003 95: 1394; doi:10.1093/jnci/djg045 [Abstract] [Full Text] [PDF]  

Lawrence S. Engel, Wong–Ho Chow, Thomas L. Vaughan, Marilie D. Gammon, Harvey A. Risch, Janet L. Stanford, Janet B. Schoenberg, Susan T. Mayne, Robert Dubrow, Heidrun Rotterdam, A. Brian West, Martin Blaser, William J. Blot, Mitchell H. Gail, and Joseph F. Fraumeni, Jr.

Population Attributable Risks of Esophageal and Gastric Cancers
J. Natl. Cancer Inst. 2003 95: 1404; doi:10.1093/jnci/djg047 [Abstract] [Full Text] [PDF]  

BRIEF COMMUNICATIONS

Philip R. Taylor, You-Lin Qiao, Christian C. Abnet, Sanford M. Dawsey, Chung S. Yang, Elaine W. Gunter, Wen Wang, William J. Blot, Zhi-Wei Dong, and Steven D. Mark

Prospective Study of Serum Vitamin E Levels and Esophageal and Gastric Cancers
J. Natl. Cancer Inst. 2003 95: 1414; doi:10.1093/jnci/djg044 [Abstract] [Full Text] [PDF]  

CORRESPONDENCE

Frédérique Spyratos, Cécile Bouchet, Magali Ferrero-Poüs, Michèle Tubiana-Hulin, and Kamel Hacène

Re: Quantitative Association Between HER-2/neu and Steroid Hormone Receptors in Hormone Receptor-Positive Primary Breast Cancer
J. Natl. Cancer Inst. 2003 95: 1417; doi:10.1093/jnci/djg068 [Extract] [Full Text] [PDF]  

Gottfried Konecny, Mark Pegram, and Dennis J. Slamon

RESPONSE: Re: Quantitative Association Between HER-2/neu and Steroid Hormone Receptors in Hormone Receptor-Positive Primary Breast Cancer
J. Natl. Cancer Inst. 2003 95: 1418; doi:10.1093/jnci/djg069 [Extract] [Full Text] [PDF]  

IN THIS ISSUE

J. Natl. Cancer Inst. 2003 95: 1349; doi:10.1093/jnci/95.18.1349-b [Extract] [Full Text] [Japanese Translation]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.